Clinical effects of combination therapy of etimicin sulfate and montmorillonite powder on acute bacillary dysentery
DOI:
Author:
Affiliation:

Clc Number:

R516.4

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Comments
    Abstract:

    ObjectiveTo observe the clinical effects of combination therapy of etimicin sulfate and montmorillonite powder on acute bacillary dysentery.MethodsThree hundred and twentysix patients were randomly divided into two groups: 182 patients in treatment group were  treated with combination of etimicin sulfate 0.2 g (added into 250 mL saline solution) intravenous drip for consecutive 3~5 days and montmorillonite powder orally (3 g/time, 3 times/day, the initial dose was doubled); 144 patients in control group were treated with etimicin sulfate intravenous drip with the same dose. Clinical therapeutic effect in two groups was observed.ResultsThe clinical effective rates were 93.96% (171/182) and 81.25%(171/144) in treatment and control group respectively, clinical effective rate in treatment group was significantly higher than that of control group (χ2=6.32, P<0.05); the average treatment course in treatment and control group were (2.04±0.48) and (3.12±0.71)days respectively, the former was obviously shorter than the latter(t=2.57, P<0.05) .ConclusionCombination therapy of etimicin sulfate and montmorillonite powder is an effective method for acute bacillary dysentery, and can shorten treatment course .

    Reference
    Related
Get Citation

王桂琴.硫酸依替米星与思密达联合治疗急性细菌性痢疾的疗效观察[J].中国感染控制杂志英文版,2010,9(5):339-340.
WANG Guiqin. Clinical effects of combination therapy of etimicin sulfate and montmorillonite powder on acute bacillary dysentery[J]. Chin J Infect Control, 2010,9(5):339-340.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:March 14,2010
  • Revised:May 29,2010
  • Adopted:
  • Online: September 30,2010
  • Published: